Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis

Keyphrases

• Amyotrophic Lateral Sclerosis 100%
• Prognostic Biomarker 100%
• Diagnostic Biomarker 100%
• Serum Neurofilament 100%
• Population-based Evidence 100%
• Neurofilament 33%
• Phosphorylated Neurofilament Heavy Chain 25%
• Prognostic Utility 25%
• Neurofilament Light (NF-L) 16%
• Population-based 16%
• Diagnostic Utility 16%
• Population Level 16%
• Serum Neurofilament Light Chain 16%
• Transferability 8%
• Clinical Trials 8%
• Renal Function 8%
• Disease Progression 8%
• Chain Level 8%
• Diagnostic Accuracy 8%
• Body Mass Index 8%
• Disease-specific 8%
• Hospital-based 8%
• Longitudinal Data 8%
• Surrogate Marker 8%
• Swabia 8%
• Age Adjustment 8%
• Index Function 8%
• Real-world Population 8%
• General Population Controls 8%
• Score Data 8%

Biochemistry, Genetics and Molecular Biology

• Neurofilament 100%
• Light Chain 50%
• Neurofilament Light 50%
• Heavy Chain 37%
• Clinical Trial 12%
• Population 12%
• Kidney Function 12%
• Body Mass 12%
• Artificial Neural Network 12%

Neuroscience

• Amyotrophic Lateral Sclerosis 100%
• Neurofilament 100%
• Neurofilament Light Chain 33%
• Heavy Chain 25%
• Body Mass Index 8%
• Artificial Neural Network 8%